Literature DB >> 16460463

FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura.

E Groot, J J J Hulstein, C N Rison, P G de Groot, R Fijnheer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460463     DOI: 10.1111/j.1538-7836.2005.01767.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

1.  Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.

Authors:  S G Shelat; P Smith; J Ai; X L Zheng
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

Review 2.  Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

3.  ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcome.

Authors:  Shangbin Yang; Ming Jin; Shili Lin; Spero Cataland; Haifeng Wu
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

4.  ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.

Authors:  Chong H Kim; Sierra C Simmons; Lance A Williams; Elizabeth M Staley; X Long Zheng; Huy P Pham
Journal:  Transfusion       Date:  2017-06-23       Impact factor: 3.157

5.  Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.

Authors:  Silvita Fitri Riswari; Rahajeng N Tunjungputri; Vesla Kullaya; Fadel M Garishah; Gloria S R Utari; Nur Farhanah; Gijs J Overheul; Bachti Alisjahbana; M Hussein Gasem; Rolf T Urbanus; Philip G de Groot; Dirk J Lefeber; Ronald P van Rij; Andre van der Ven; Quirijn de Mast
Journal:  PLoS Pathog       Date:  2019-03-08       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.